<DOC>
	<DOC>NCT02535611</DOC>
	<brief_summary>The researchers aim to investigate the effect of memantine on stroke outcome in a randomized double-blind placebo-controlled clinical trial.</brief_summary>
	<brief_title>Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>Presentation at first 24hrs of disease onset Confirmation of ischemic stroke in MCA territory by imaging. Accepted consent form Allergy history to memantine Stage 4 5 renal failure base on Acute Kidney Injury Network criteria Moderate to severe hepatic failure (ChildPugh criteria, grade B and C) History of epilepsy History of dementia History of memantine use in recent 6 months Pregnancy or breastfeeding Severe drug adverse effects</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>